VivoSeq
Other

Periodontal Diseases

0

Pipeline Programs

8

Active Trials

1

Companies Involved

Periodontal Diseases is an early-stage landscape with 0 programs across 1 company. The most active players are Dongkook Pharmaceutical Co., Ltd..

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed9 · 47%
Not yet recruiting4 · 21%
Recruiting4 · 21%
Unknown status2 · 11%

Trial Activity

19 trials

Oral and Systemic Levels of TFF-1 and TTF-3 in Periodontal Diseases
Completed··N/A·NCT04407026·100 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)